Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone

Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone

Background and Aim. Lubiprostone is a novel laxative that sometimes causes nausea, but preventive strategies remain unconfirmed. Methods. We retrospectively chose 126 patients prescribed lubiprostone from 2013 to 2016. Medical records were reviewed to clarify whether nausea developed after administr...

Full description

Bibliographic Details
Main Authors:	Takatsugu Yamamoto, Shun Osumi, Daisuke Yanagisawa, Hiroshi Yamato, Hitoshi Aoyagi, Akari Isono, Koichiro Abe, Hiroto Kita
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/3762179

Similar Items

Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants
by: Kyohei Maruyama, et al.
Published: (2018-01-01)

Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
by: Kazumi Inokuchi, et al.
Published: (2021-06-01)

Lubiprostone stimulates small intestinal mucin release
by: De Lisle Robert C
Published: (2012-11-01)

Lubiprostone: a novel treatment for chronic constipation
by: Brian E Lacy, et al.
Published: (2008-06-01)

Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
by: De Lisle Robert C, et al.
Published: (2010-09-01)

Evaluating lubiprostone for effective bowel preparation before colonoscopy
by: Yasser Hamada, et al.
Published: (2021-03-01)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
by: Mahmoud Soubra, et al.
Published: (2012-04-01)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
by: Mahmoud Soubra, et al.
Published: (2012-01-01)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
by: Gras-Miralles B, et al.
Published: (2013-02-01)

Prescription pattern & adverse drug reactions of prokinetics
by: Mansij Biswas, et al.
Published: (2019-01-01)

Effects of Prokinetic Agents on Motility of Proximal and Distal Colon
by: Mehmet Şerif Arslan, et al.
Published: (2016-03-01)

Role of Prokinetic Agents in the Treatment of Gastroesophagael Reflux Disease
by: Michel Boivin
Published: (1993-01-01)

The Laxative and Prokinetic Effects of Rosa damascena Mill in Rats
by: Reza Arezoomandan, et al.
Published: (2011-01-01)

Prokinetic activity of strictinin in raw pu-erh tea
by: Jun-Rui Xu, et al.
Published: (2015)

Place and choice of prokinetic in treatment of gastroesophageal reflux disease
by: V. I. Kasyanenko
Published: (2013-12-01)

New Developments in Prokinetic Therapy for Gastric Motility Disorders
by: Michael Camilleri, et al.
Published: (2021-08-01)

Modern options of prokinetics in gastroesophageal reflux disease treatment
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Therapeutic role of prokinetic drugs in the treatment of gastroesophageal reflux disease
by: I. V. Mayev, et al.
Published: (2014-12-01)

Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis
by: Young Joo Yang, et al.
Published: (2017-06-01)

Lavage, Simethicone, and Prokinetics—What to Swallow with a Video Capsule
by: Martin Keuchel, et al.
Published: (2021-09-01)

Species and tissue-specificity of prokinetic, laxative and spasmodic effects of <it>Fumaria </it><it>parviflora</it>
by: Najeeb-ur-Rehman, et al.
Published: (2012-03-01)

Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
by: Chien-Hsu Lai, et al.
Published: (2019-06-01)

A Prokinetic Agent with a Dual Effect – Itopride – In the Treatment of Dysmotility
by: Petr Dite, et al.
Published: (2014-12-01)

A Meta-Analysis of the Efficacy of Prokinetic Agents against Glycemic Control
by: Yeon-Ji Kim, et al.
Published: (2019-01-01)

COMPARISON OF PROKINETIC ACTIVITY OF RANITIDINE AND NEOSTIGMINE ALONE AND IN COMBINATION- AN IN VITRO STUDY
by: Aroosa Ishtiaq Butt, et al.
Published: (2021-01-01)

The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia
by: Ju Yup Lee
Published: (2021-04-01)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
by: Arpita Nag, et al.
Published: (2020-08-01)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
by: Tisha N Lunsford, et al.
Published: (2010-10-01)

Stimulation of gastroduodenal HCO3- secretion by lubiprostone mediated by different prostaglandin EP receptor subtypes
by: Koji Takeuchi, et al.
Published: (2020-06-01)

Antidepression and Prokinetic Effects of Paeoniflorin on Rats in the Forced Swimming Test via Polypharmacology
by: Dao-zhou Mu, et al.
Published: (2020-01-01)

The Feasibility and Validity of Prokinetic Prescription in Children with Chronic Gastroduodenal Pathology and Lesions of the Pancreas
by: Z.V. Tomkiv, et al.
Published: (2014-05-01)

Laryngopharyngeal Reflux Disease - Do Prokinetic Drugs have any Role in Management?
by: Rahul Sarkar, et al.
Published: (2014-06-01)

Can the Combination of Famotidine and Prokinetics Have Additional Effects on Gastric Acid Suppression?
by: Yoon Jin Choi
Published: (2021-09-01)

Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
by: Hiraku Akita, et al.
Published: (2020-04-01)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
by: Hayat M, et al.
Published: (2019-02-01)

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
by: Takayuki Kato, et al.
Published: (2017-01-01)

FUNCTIONAL GASTROINTESTINAL DISORDERS: SELECT FROM THE POINT PROKINETIC COMORBIDITY, CLINICAL EFFICACY AND DRUG SAFETY
by: D. I. Trukhan
Published: (2017-12-01)

Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study
by: Sood Manu R, et al.
Published: (2008-08-01)

Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
by: Kentaro Arakawa, et al.
Published: (2019-01-01)

Prokinetic Activity of Prunus persica (L.) Batsch Flowers Extract and Its Possible Mechanism of Action in Rats
by: Wei Han, et al.
Published: (2015-01-01)